Yan Jiao | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Dr. Yan Jiao | Cancer Cell Biology | Best Researcher Award

Dr. Yan Jiao, First Hospital of Jilin University, China

Dr. Yan Jiao is an accomplished Attending Physician and clinical researcher at the First Hospital of Jilin University, specializing in hepatobiliary and pancreatic diseases. With dual degrees—a Bachelor of Medicine and a Ph.D. from Jilin University—Dr. Jiao has combined clinical acumen with deep expertise in bioinformatics and statistical analysis. A prolific researcher, Dr. Jiao has published extensively on topics ranging from liver cancer and immunotherapy to the adverse effects of diagnostic dyes and post-surgical complications. Notably, Dr. Jiao has contributed to scientific integrity through independent verification of published data and has reported anomalies that led to editorial actions. Skilled in R programming and mining public health datasets, Dr. Jiao blends analytical precision with a commitment to improving patient outcomes. Recognized for a meticulous approach to research, Dr. Jiao’s work exemplifies scientific rigor and ethical responsibility, making a compelling case for the Best Researcher Award.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Outstanding Publication Record:
    Dr. Jiao has co-authored over 20 peer-reviewed journal articles in high-impact journals like Scientific Reports, International Journal of Nanomedicine, and World Journal of Gastrointestinal Surgery. The research spans critical fields like liver cancer, gastric cancer, bioinformatics, and surgical safety, demonstrating multidisciplinary excellence.

  2. High Ethical Standards:
    A rare and commendable contribution is Dr. Jiao’s work in scientific integrity—verifying published studies, detecting image manipulation, and triggering investigations into misconduct. This highlights not only academic rigor but also moral responsibility in research.

  3. Bioinformatics Expertise:
    Proficient in R programming and analysis of large public datasets (FAERS, NHANES, TCGA), Dr. Jiao merges clinical insight with data science to generate real-world impact. The capacity to handle complex data with statistical precision is vital in modern medical research.

  4. Clinical & Research Integration:
    As a practicing Attending Physician in hepatobiliary and pancreatic diseases, Dr. Jiao directly applies research outcomes to clinical settings. This dual competency strengthens translational research and improves patient-centered outcomes.

  5. Collaborative Network:
    Dr. Jiao has worked with a wide range of co-authors, showing adaptability and a collaborative spirit. This not only strengthens individual studies but also reflects influence within a broader research community.

🛠️ Areas for Improvement:

  1. Global Research Visibility:
    While Dr. Jiao has a strong publication portfolio, more engagement with global conferences, keynote presentations, and international collaborations would enhance international recognition.

  2. Grant Leadership:
    There is limited information on independent research funding or grant leadership. Applying for and leading funded projects could further establish Dr. Jiao’s credentials as a principal investigator.

  3. First-Author Publications:
    Though a frequent contributor, a higher proportion of first-author or corresponding-author roles would solidify recognition as a lead researcher, particularly in high-impact original studies.

🎓 Education:

Dr. Yan Jiao pursued both undergraduate and doctoral studies at Jilin University, one of China’s top research institutions. From 2011 to 2016, Dr. Jiao earned a Bachelor of Medicine, laying the groundwork in clinical sciences and human biology. Continuing seamlessly into advanced research, Dr. Jiao completed a Ph.D. at the same university from 2016 to 2019, with a focus on hepatobiliary diseases and translational bioinformatics. The doctoral training combined clinical exposure with robust coursework in molecular biology, epidemiology, and data science. This dual qualification reflects a rare integration of frontline medical experience and deep academic inquiry, preparing Dr. Jiao for a career at the intersection of medicine, research, and technological innovation. Throughout academic training, Dr. Jiao demonstrated a strong aptitude for evidence-based medicine and statistical modeling, gaining recognition for a disciplined and inquisitive approach. The education path reflects a trajectory of consistent excellence and interdisciplinary competence.

💼 Professional Experience:

Dr. Yan Jiao currently serves as an Attending Physician at the First Hospital of Jilin University, where the clinical focus lies in hepatobiliary and pancreatic diseases. In this role, Dr. Jiao combines patient care with research initiatives, particularly in liver cancer. Beyond clinical duties, Dr. Jiao is actively engaged in bioinformatics research, utilizing datasets like FAERS, TCGA, and NHANES to uncover patterns in disease and treatment outcomes. With expert-level proficiency in R programming, Dr. Jiao conducts complex statistical analyses and visualizations. A distinct part of Dr. Jiao’s experience involves auditing the scientific literature for data anomalies and image manipulation, contributing anonymously to investigations into research misconduct. This dual role as a clinician and data scientist uniquely positions Dr. Jiao to address both practical and theoretical challenges in healthcare. Dr. Jiao’s professional journey underscores a rare blend of technical skills, ethical vigilance, and medical expertise, reinforcing eligibility for prestigious research awards.

🔬 Research Focus:

Dr. Yan Jiao’s research is deeply rooted in hepatobiliary oncology, with a specific focus on liver cancer diagnosis, treatment strategies, and prognosis modeling. Integrating clinical insights with computational analysis, Dr. Jiao utilizes large public datasets like TCGA, FAERS, and NHANES to examine treatment efficacy, drug safety, and genetic risk factors. A significant thrust of the research lies in immunotherapy, chemoembolization techniques, and the safety of diagnostic agents like Indocyanine Green. Dr. Jiao also explores post-operative complications and gastrointestinal disorders, broadening the scope of clinical relevance. Equally important is the investigation into scientific integrity, where Dr. Jiao’s efforts in identifying manipulated data and statistical inconsistencies have led to editorial scrutiny in major journals. By bridging bioinformatics with hands-on medical practice, the research offers both theoretical advancements and actionable clinical solutions. Dr. Jiao’s focus is future-facing, centered on personalized treatment and real-world data analysis to optimize patient outcomes.

📚 Publications Top Notes:

  1. 📉 Obesity-Surgery is not the end.

  2. 💉 Landscape of transarterial chemoembolization for hepatocellular carcinoma.

  3. 🧬 Immunotherapy for metastatic gastric cancer.

  4. ⚠️ Exploring the dark side of diagnostic dyes – Indocyanine green.

  5. 🧬 Long non-coding RNA HOTAIR in liver cancer cell behavior.

  6. 🧪 Abraxane-related adverse events – FAERS decade-long analysis.

  7. 🧬 Personalized treatment of perihilar cholangiocarcinoma.

  8. 💊 Impact of immunotherapy on liver metastasis.

  9. 🏥 Incisional hernia after laparoscopic colorectal surgery.

  10. 🔍 Intestinal Behçet’s disease: Diagnosis and treatment.

🧾 Conclusion:

Dr. Yan Jiao is a highly qualified and deserving candidate for the Best Researcher Award. With an exceptional combination of clinical experience, research productivity, ethical vigilance, and bioinformatics expertise, Dr. Jiao stands out as a well-rounded and impactful medical scientist. While there is room to further elevate global visibility and leadership in grant-funded research, the current portfolio already reflects excellence in translational science and data-driven healthcare. In conclusion, Dr. Jiao’s contributions are not only prolific but principled—making this nomination both timely and justified.

Noureddine Allouche | Molecular Mechanisms Signaling | Best Research Article Award

Posted on by sciencefather

Prof. Noureddine Allouche | Molecular Mechanisms Signaling | Best Research Article Award

Prof. Noureddine Allouche , Faculty of Sciences of Sfax, University of Sfax , Tunisia

Professor Noureddine Allouche, born in 1971, is a Full Professor of Chemistry at the Faculty of Sciences of Sfax (FSS), Tunisia. He is the Head of the Natural Substances Team in the Laboratory of Organic Chemistry. With over 150 peer-reviewed publications, an h-index of 35, and more than 4500 citations, he is recognized for his impactful research on natural products and environmental valorization. He has led and contributed to multiple national and European research projects, including FP7, H2020, Erasmus+, and ARIMNET. His work focuses on extraction, isolation, and bioactivity of plant-based compounds and sustainable management of industrial waste. Prof. Allouche has supervised 20 Ph.D. theses and 42 M.Sc. students, contributing significantly to scientific advancement in Tunisia and beyond. He is also involved in applied research in green chemistry and cosmetic sciences. His collaborative work and leadership have earned him recognition in the academic and research communities.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. High Research Productivity and Impact

    • Over 150 peer-reviewed scientific articles with a h-index of 35 and 4,500+ citations, which reflect sustained academic influence and quality.

    • Contributor to top-tier journals such as Plants, Biomolecules, and Molecules.

  2. Strong Focus on Societal Relevance

    • Work addresses critical environmental issues such as olive mill waste valorisation, bioconversion, and sustainable resource use.

    • Research applied in green chemistry, natural product-based pharmaceuticals, and eco-cosmetics.

  3. International Collaboration and Leadership

    • Coordinator of six major European and international research projects (FP7, H2020, Erasmus+, ARIMNET).

    • Active partnerships with institutions in France, Germany, and the Mediterranean region, showcasing leadership in multidisciplinary and multinational research.

  4. Methodological Rigor and Innovation

    • Use of advanced analytical techniques (e.g., HPLC-HESI-MS/MS, LC-MS/MS, ESI-MS/MS).

    • Integration of green technologies for natural substance extraction.

  5. Mentorship and Academic Development

    • Supervised 20 Ph.D. theses (plus 4 ongoing), 42 Master’s theses, and numerous diploma projects, especially in applied fields like cosmetic science.

🛠️ Areas for Improvement:

  1. Broader International Recognition

    • While highly active in regional and EU collaborations, increased visibility in global North America/Asia-led consortia or global forums could enhance recognition.

  2. Science Communication and Outreach

    • Publishing in public engagement platforms or delivering talks/webinars to non-specialist audiences could expand the impact of his research beyond academia.

  3. Open Access and Data Sharing

    • Encouraging open data practices and reproducibility of extraction and formulation protocols could enhance scientific transparency and citations.

🎓 Education:

Professor Noureddine Allouche earned his Ph.D. in Chemistry from the University of Sfax between 2000 and 2005, focusing on the treatment and valorisation of olive mill waste, a subject that would lay the foundation for his future research career. Following this, he undertook a prestigious postdoctoral training (2006–2007) at the Institute of Natural Products Chemistry of CNRS in Gif-sur-Yvette, France, enhancing his expertise in natural substances and analytical chemistry. His academic foundation was built on rigorous training in organic chemistry, natural products, and environmental biotechnology. These experiences equipped him with robust research methodologies and an interdisciplinary approach, especially in the extraction and biological evaluation of phytochemicals. His educational path reflects a strong commitment to green and sustainable chemistry, positioning him well for leading high-impact research on natural product development and eco-friendly industrial applications.

💼 Experience:

Professor Allouche has over 20 years of academic and research experience. He currently leads the Natural Substances Team at the Faculty of Sciences of Sfax and supervises a group of over 20 researchers. He has played a vital role in international research collaborations, serving as the national coordinator of six European-funded projects under FP7, ARIMNET, H2020, Erasmus+, and PHC-Maghreb. His experience also includes participation in the INCO-MED project on detoxification and recovery from olive mill wastewater. Prof. Allouche has an extensive mentoring portfolio, having supervised 20 Ph.D. theses (with 4 ongoing) and 42 M.Sc. students. He has authored 150+ articles, two book chapters, and holds two patents. His career reflects a blend of scientific innovation and applied industrial research, particularly in green technologies, bioactive compounds, and waste valorisation. He is also a regular collaborator with European institutions, reflecting his global outlook and leadership in sustainable science.

🔍 Research Focus:

Prof. Noureddine Allouche’s research centers on natural substances chemistry, green extraction methods, and biotechnological valorisation of industrial wastes, particularly from agro-food sources. He has made significant contributions to the identification and biological evaluation of bioactive compounds such as phenolics, flavonoids, and essential oils. His team is particularly active in analyzing plant extracts for their antioxidant, antimicrobial, cytotoxic, and anti-aging activities, often employing advanced techniques like HPLC, LC-MS/MS, and ESI-MS/MS. Another pillar of his work includes developing biopesticides and bio-cosmetics through green and eco-sustainable approaches. He contributes to nanoformulation research and the design of nature-based products aligned with circular economy principles. His interdisciplinary projects bridge chemistry, pharmacology, environmental science, and cosmetic formulation, making his research highly relevant for addressing current scientific and industrial challenges. His recent involvement in projects like GreenCosmIn and 25MAG23 reflects his leading role in European research on sustainable innovation.

📚 Publications Top Notes:

  1. 🌿 HPLC-HESI-MS/MS Analysis of Phenolic Compounds from Cynoglossum tubiflorus Leaf Extracts (Plants, 2024)

  2. 🫒 Intensification of Biophenols Extraction Yield from Olive Pomace Using Innovative Green Technologies (Biomolecules, 2022)

  3. 🌸 Antioxidant and Antimicrobial Activities of Erodium arborescens Extracts Characterized by LC-HESI-MS² (Molecules, 2022)

  4. 🌿 ESI-MS/MS Analysis of Aeonium arboreum Leaf Extracts and Evaluation of Antioxidant and Antimicrobial Activities (Molecules, 2021)

  5. 🍇 Novel Natural Products for Healthy Ageing from Mediterranean Diet – The MediHealth Project (Molecules, 2018)

🧾 Conclusion:

Professor Noureddine Allouche stands out as a highly qualified and deserving candidate for the Best Research Article Award. His impressive record in sustainable chemistry, natural products research, international project coordination, and scholarly mentorship underlines his academic excellence and real-world impact. His research directly contributes to health, environmental sustainability, and circular economy principles, aligning well with the goals of high-impact, solution-driven science.

Balbino Alarcón | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Balbino Alarcón | Cancer Cell Biology | Best Researcher Award

Prof. Dr. Balbino Alarcón , Consejo Superior de Investigaciones Científicas , Spain

Balbino Alarcón is a leading Spanish immunologist renowned for his contributions to T cell biology and immune signaling. Currently serving as Profesor de Investigación at the Consejo Superior de Investigaciones Científicas (CSIC), he has been affiliated with the Centro de Biología Molecular Severo Ochoa since 2002. His research has played a pivotal role in uncovering mechanisms of T cell receptor (TCR) signaling and immune system regulation. Dr. Alarcón holds a PhD in Biology from the Universidad Autónoma de Madrid, where he began shaping his scientific journey in the early 1980s. Over the decades, he has authored numerous impactful publications, many in top-tier journals, and holds several patents licensed to biotech companies. His work bridges fundamental immunology with translational applications in autoimmunity and cancer. With a keen focus on molecular signaling, his research continues to influence both basic science and therapeutic innovation in immunology.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Outstanding Research Contributions:
    Dr. Alarcón has made seminal contributions to immunology, especially in T cell receptor (TCR) signaling, immune synapse formation, and immune cell communication. His work has appeared in top-tier journals like Cell, Immunity, Nature Communications, and Journal of Experimental Medicine.

  2. Impactful Publications & Citations:
    His research includes several highly cited papers (e.g., >500 citations), underlining the influence of his work on the broader scientific community.

  3. Translational Achievements:
    He holds multiple patents on immunomodulatory molecules (e.g., AX-024), which were licensed to biotech company Artax Biopharma, bridging basic science and clinical application.

  4. SARS-CoV-2 Research Leadership:
    He actively contributed to COVID-19 immunity research, developing flow cytometry-based antibody detection techniques and tracking longitudinal immune responses to infection and vaccination.

  5. Longevity and Commitment:
    Over 40 years of consistent research activity, with continuous affiliation to one of Spain’s most prestigious scientific institutions, CSIC.

  6. International Collaboration:
    He co-authored papers with leaders in immunology, showing global recognition and collaboration.

🛠️ Areas for Improvement:

  • Public Engagement & Visibility:
    Despite scientific acclaim, more visibility in public science communication, conference keynote roles, or leadership in global immunology consortia would further support his candidacy.

  • Mentorship Highlighting:
    While his academic stature suggests mentorship, documentation or awards for training young scientists could enhance his profile for broader awards recognizing holistic impact.

  • Innovation Metrics:
    Increased emphasis on clinical translation or successful product development from his patents could strengthen claims to innovation-driven recognitions.

🎓 Education:

Dr. Balbino Alarcón completed his undergraduate degree (Licenciado en Biología) in 1982 and his PhD in Biology with a specialization in Biochemistry in 1985, both from the Universidad Autónoma de Madrid, Spain. During his academic formation, he developed a deep interest in immunological signaling, particularly in how T cells communicate with their environment. His early education laid the foundation for a distinguished research career that has spanned more than three decades. His doctoral studies were focused on cellular and molecular immunology, equipping him with the tools to explore intricate signaling pathways. This robust educational background positioned him for leadership roles in immunological research, both nationally and internationally. Through rigorous academic training and continuous research contributions, Dr. Alarcón has become a key figure in advancing our understanding of T cell function and immune regulation.

👨‍🔬 Experience:

Dr. Balbino Alarcón has over 40 years of experience in immunological research, with a primary focus on T cell receptor (TCR) signaling and lymphocyte activation. Since July 27, 2002, he has held the position of Profesor de Investigación at the Consejo Superior de Investigaciones Científicas (CSIC), working at the Centro de Biología Molecular Severo Ochoa in Madrid, Spain. His academic and research career began with groundbreaking studies in T cell immunobiology, leading to discoveries such as the role of conformational changes in TCR activation. Dr. Alarcón has also been deeply involved in translational research, co-developing immunomodulatory drugs and securing patents that were licensed to Artax Biopharma. He regularly collaborates with leading immunologists and institutions worldwide, contributing to high-impact publications and international scientific reviews. His expertise and sustained contributions have made him a mentor and authority in molecular immunology and T cell biology.

🏅 Awards and Honors:

Dr. Balbino Alarcón’s distinguished career is highlighted by several prestigious awards and intellectual property recognitions. He co-developed two patented immunosuppressive strategies based on TCR signaling inhibition: one disrupting the TCR-Nck interaction and another involving chromene derivatives. Both patents were licensed to Artax Biopharma, showcasing the real-world therapeutic relevance of his research. He has authored highly cited publications, including foundational work published in Cell, Immunity, and Annual Review of Immunology, with citations in the hundreds. These contributions have not only advanced the field of immunology but also positioned Dr. Alarcón as a thought leader in immune signal transduction. He has been recognized nationally and internationally for his scientific achievements, serving as an editorial contributor and co-author of influential immunological reviews. His work continues to shape both academic and pharmaceutical research, making him a strong candidate for Best Researcher Awards.

🔬 Research Focus:

Dr. Alarcón’s research centers on the molecular mechanisms governing T cell receptor (TCR) activation and signal transduction. His work dissects how T cells recognize antigens and how intracellular signaling cascades translate these interactions into immune responses. A significant aspect of his research has involved understanding the conformational dynamics of the TCR/CD3 complex and how this affects T cell sensitivity and activation thresholds. He also explores the role of RRas2 in T and B cell function, including its relevance in lymphomagenesis and autoimmunity. Recently, he has contributed to understanding immune responses to SARS-CoV-2 and methods to detect neutralizing antibodies. His interdisciplinary approach integrates cell biology, molecular immunology, and translational research, linking fundamental science to clinical applications such as vaccine development and immunotherapy. By targeting TCR-associated pathways, Dr. Alarcón’s research opens new avenues in the treatment of immune-related diseases and cancer.

📚 Publications Top Notes:

  1. 🧫 RRas2 is required for germinal center formation to aid B cells during energetically demanding processes (Sci Signal, 2018)

  2. 🧪 A window of opportunity for cooperativity in the T Cell Receptor (Nat Commun, 2018)

  3. 🧬 Antigen phagocytosis by B cells is required for a potent humoral response (EMBO Rep, 2018)

  4. ⚙️ RRAS2 shapes the TCR repertoire by setting the threshold for negative selection (J Exp Med, 2019)

  5. 💊 Small molecule AX-024 targets T cell receptor signaling by disrupting CD3ε-Nck interaction (J Biol Chem, 2020)

  6. 🧪 Flow cytometry multiplexed method for the detection of Neutralizing human antibodies to SARS-CoV-2 (EMBO Mol Med, 2021)

  7. 🧬 Antigen presentation between T-cells drives Th17 polarization under limiting antigen (Cell Rep, 2021)

  8. 🧫 Detection of sustained humoral immune response (IgG + IgA) in SARS-CoV-2 infection (Sci Rep, 2021)

  9. 🧠 SFRP1 modulates astrocyte-to-microglia crosstalk in neuroinflammation (EMBO Rep, 2021)

  10. 💉 Longitudinal dynamics of SARS-CoV-2-specific immunity after infection or vaccination (PLoS Pathog, 2021)

🧾 Conclusion:

Dr. Balbino Alarcón is a highly deserving candidate for the Best Researcher Award. His pioneering studies in T cell signaling, impactful biomedical patents, and active role in immune response to infectious diseases demonstrate excellence in both basic and translational immunology. With decades of productive research, interdisciplinary collaboration, and consistent scientific leadership, he embodies the qualities celebrated by such an award.

Audrey FERRAND | Mechanobiology | Best Researcher Award

Posted on by sciencefather

Dr. Audrey FERRAND | Mechanobiology | Best Researcher Award

Dr. Audrey FERRAND , Inserm , France

Dr. Audrey Ferrand, PhD, HDR, is a tenured senior researcher at Inserm and team leader at the Institut de Recherche en Santé Digestive (IRSD) in Toulouse, France. Born in 1975, she is a pioneering scientist in intestinal biology, with a strong international profile, including stints at Harvard Medical School and the University of Melbourne. She currently leads the “Intestinal Epithelium & Environment Interactions” team, investigating the dynamic crosstalk between intestinal epithelial cells and their environment. Dr. Ferrand has published 28 peer-reviewed articles, with an h-index of 20 and over 2100 citations. She is widely recognized for her expertise in organoids, regenerative medicine, and mechanobiology, and has coordinated multiple large-scale European research projects. A prolific speaker, educator, and scientific leader, she also plays key roles in advisory boards and national committees, contributing to cutting-edge biomedical research and innovation.

Publication Profile:

Scopus

✅ Strengths for the Award:

1. Outstanding Scientific Productivity

  • 28 peer-reviewed publications and 7 review articles.

  • Strong Google Scholar profile (h-index 20; 2122 citations).

  • Recent high-impact publications in PLoS Computational Biology, Journal of Pathology, and Cell Reports.

2. Research Leadership & Innovation

  • Team Leader at Inserm since 2021.

  • Leads the “Intestinal Epithelium & Environment Interactions” team, a hub of innovation in gut biology and organoid models.

  • Coordinated 6 major funded research projects since 2020 totaling over €2 million.

3. International Experience & Visibility

  • Research experience in USA (Harvard Medical School), Australia (University of Melbourne), and France.

  • Speaker at top-tier global events (e.g., Columbia University, European Society of Biomaterials, Franco-Taiwanese Conference).

4. Scientific Contribution to Society

  • Serves on multiple scientific advisory boards, including PEPR MED’OOC, RIBBON, and GIS FC3R.

  • Expert reviewer for national and international funding bodies (France, Belgium, Poland, Israel, UKRI).

  • Contributes to PhD juries (25+) and teaches extensively (40 hours/year).

5. Strategic National & EU-Level Engagement

  • Holds national roles in emerging tech programs like organ-on-chip (OOC) and regenerative medicine.

  • Member of key executive and scientific committees shaping the future of translational bioengineering.

⚖️ Areas for Improvement:

  1. Higher Impact Journal Penetration

    • While the publication output is solid, additional publications in ultra-high impact journals (Nature, Science, Cell) could increase visibility.

  2. Public & Industry Engagement

    • Although involved in translational programs, stronger partnerships with biotech startups or patient advocacy initiatives could further amplify societal impact.

  3. Technology Transfer or Patents

    • No mention of patents or commercial spin-offs, which could strengthen application in innovation-oriented award contexts.

🎓 Education:

Dr. Audrey Ferrand holds a PhD in Life Sciences and an HDR (Habilitation to Direct Research), signifying her capability to lead doctoral research in France. Although specific universities for her doctoral studies are not listed, her academic pedigree includes postdoctoral training at internationally prestigious institutions such as Harvard Medical School’s MGH Cancer Center (2005–2006) and the University of Melbourne’s Department of Surgery (2006–2009). Her formative training laid the foundation for her long-standing focus on cancer biology, intestinal pathophysiology, and bioengineering. She has continued to enhance her expertise through involvement in multidisciplinary projects combining molecular biology, systems biology, and biomedical engineering. In parallel, Dr. Ferrand contributes significantly to academic training, teaching over 40 hours per year at Bachelor and Master levels in fields including pharmacology, tissue engineering, metabolism, and cancerology.

🧪 Experience:

Dr. Ferrand has over 20 years of experience in biomedical research. Since 2009, she has held a tenured position at Inserm (CR1 level), becoming a team leader at IRSD in 2021. Her career spans international settings, including the MGH Cancer Center (Harvard Medical School) and the University of Melbourne, where she worked on translational cancer research. As team leader of “Intestinal Epithelium & Environment Interactions,” she leads interdisciplinary projects on gut biology, organoids, and microphysiological systems. She has also taken on pivotal roles in project coordination, scientific councils, ethics committees, and PhD supervision. Notably, she serves on national and international advisory boards such as PEPR MED’OOC and GIS FC3R. Beyond research, Dr. Ferrand has organized numerous conferences and thematic workshops in organoids, 3D imaging, and cancer bioengineering. Her proven track record reflects her leadership, innovation, and dedication to translational research in digestive health.

🔬 Research Focus:

Dr. Ferrand’s research focuses on the mechanobiology and pathophysiology of the intestinal epithelium using advanced 3D culture systems and organoids. She investigates the interaction between intestinal cells and their microenvironment, particularly how physical and chemical signals regulate tissue homeostasis, regeneration, and disease. Her group is pioneering efforts in the development of colon-on-chip platforms and 3D bioprinting for high-throughput drug screening and modeling gastrointestinal diseases such as colorectal cancer and inflammatory bowel disease. Dr. Ferrand’s projects are highly interdisciplinary, combining cell biology, engineering, and computational modeling. Her leadership in PEPR MED-OOC and other EU-funded initiatives showcases her vision for integrating organoid-based technologies into precision medicine. With strong collaborations across academia and industry, her team plays a key role in shaping the future of regenerative medicine and intestinal health research.

📚 Publications Top Notes:

  1. 🧠 Deciphering cell behavior using a finite element-based vertex organoid model – PLoS Comput Biol, 2025

  2. 🧬 Human colonic organoids to study familial adenomatous polyposis – J Pathol, 2025

  3. 🔍 20S Proteasome profiling from patient samples using Top-Down MS – Cells, 2023

  4. 🔗 Multiscale intestinal cell dynamics and gene networks – Cell Rep, 2021

  5. 🔧 Stromal-epithelial interactions in gut homeostasis and disease – Front Cell Dev Biol, 2021

  6. 🧫 Mechanosensing and epithelial morphogenesis – Front Cell Dev Biol, 2020

🧾 Conclusion:

Dr. Audrey Ferrand stands out as a highly accomplished, visionary, and influential researcher in the fields of intestinal biology, organoid systems, and mechanobiology. Her interdisciplinary approach, combining biology, engineering, and medicine, positions her at the forefront of innovation in gut research and 3D tissue modeling.

Esmail El-Fakharany | cell biology | Best Researcher Award

Posted on by sciencefather

Prof. Esmail El-Fakharany | cell biology | Best Researcher Award

Prof. Esmail El-Fakharany  , city of scientific research and technological applications , Egypt

Dr. Tamer Abdelrazik is a distinguished researcher in the field of biological sciences and biotechnology, specializing in microbiology, virology, and the preparation of therapeutic agents. He has contributed significantly to the scientific community with over 102 published papers and 16 book chapters. Dr. Abdelrazik holds an esteemed academic position as a part-time research fellow at Pharos University in Alexandria and the Pharmaceutical and Fermentation Industries Development Centre (PFIDC), Alexandria, Egypt. He is also recognized for his leadership as the principal investigator of several funded research projects, focusing on COVID-19 treatments, cancer therapeutics, and environmental technologies. Dr. Abdelrazik’s academic and research achievements have led to his recognition in Stanford’s ranking of the top 2% of impacting scientists globally.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Tamer Abdelrazik demonstrates exceptional research achievements in the fields of biological sciences, biotechnology, and applied biomedical sciences. His impressive track record includes over 102 journal papers and 16 book chapters, with significant contributions to the understanding of antimicrobial agents, cancer therapies, and novel drug delivery systems. Notably, his leadership on projects like “Lactoferrin-Zinc nanocombinations for COVID-19” reflects his innovative approach in addressing global health challenges. Additionally, his inclusion in Stanford’s top 2% ranking of impacting scientists for 2023 showcases his prominence and impact in scientific research. His high H-index (28) and academic supervision of 9 M.Sc. and 13 Ph.D. students highlight his dedication to advancing research and mentoring future scientists.

Areas for Improvement:

While Dr. Abdelrazik’s research output is impressive, expanding the scope of his studies into other emerging fields such as AI-driven drug discovery or sustainability in biomedical engineering could strengthen his scientific legacy. Further interdisciplinary collaborations could also enhance his research portfolio, bringing new perspectives into his work.

Education:

Dr. Tamer Abdelrazik holds an extensive academic background in biological sciences and biotechnology. His early academic training was conducted at recognized institutions in Egypt, followed by advanced studies leading to multiple degrees in the field of microbiology, immunology, and biochemistry. His educational journey enabled him to hone expertise in molecular biology, protein chemistry, tissue culture, and the study of antiviral and anticancer agents. Throughout his academic tenure, Dr. Abdelrazik demonstrated excellence in both theoretical knowledge and experimental practices, often publishing the outcomes of his studies in high-impact journals. He continues to guide future researchers through his supervision of several MSc and Ph.D. students. His education in both the practical and theoretical aspects of biomedical sciences underpins his success as a prominent researcher in various subfields, including therapeutic protein development and environmental biotechnology.

Experience:

Dr. Tamer Abdelrazik’s professional career spans over 15 years, during which he has built a reputation as a leading researcher in the fields of microbiology, biotechnology, and molecular biology. He started his career as a lab specialist at the National Research Centre, Cairo, where he worked from 2006 to 2011. Since 2023, he has held part-time research fellowships at Pharos University and PFIDC, Alexandria, Egypt. In addition to his research duties, he has served as a mentor, advising 9 MSc and 13 Ph.D. students. Dr. Abdelrazik has been the principal investigator on numerous grant-funded projects, focusing on advanced therapies for cancer, COVID-19, and environmental issues. His innovative work, particularly in the development of antimicrobial filters, nanomedicines, and drug delivery systems, has positioned him as a key figure in both academic and industrial research. His career is marked by constant collaboration with national and international research institutions.

Awards and Honors:

Dr. Tamer Abdelrazik has been recognized for his outstanding contributions to scientific research, especially in the fields of biotechnology and medical sciences. He was awarded the prestigious State Encouragement Award in 2019 by the Egyptian Academy of Science and Technology for his advancements in medical technologies. In 2014, he received a certificate from SRTA-City for his significant research achievements and distinguished publications. More recently, Dr. Abdelrazik was ranked in the top 2% of the most impactful scientists globally by Stanford in 2023. These accolades are a testament to his contributions in developing therapeutic agents, including antiviral and anticancer treatments, and his work in environmental health technologies. Dr. Abdelrazik’s recognition by such esteemed institutions highlights his dedication to advancing scientific knowledge and improving human health. These awards solidify his status as a key figure in his field and underscore his influence on global research.

Research Focus:

Dr. Tamer Abdelrazik’s research primarily focuses on advancing medical biotechnology and environmental technologies. He is particularly known for his work in virology, microbiology, and the development of antiviral agents, with a focus on COVID-19. Additionally, his research addresses cancer therapeutics, especially the formulation of nano-complexes to treat various carcinomas. Dr. Abdelrazik’s work includes the investigation and development of novel bioactive compounds such as antimicrobial agents and the fabrication of therapeutic proteins and enzymes. His ongoing projects also explore environmental applications, such as antimicrobial air filters integrated with air-conditioning systems and water purification membranes. His research aims to merge scientific knowledge with practical solutions to address global health challenges. Moreover, he is dedicated to enhancing the delivery of therapeutic agents through innovative drug delivery systems, with a special emphasis on tissue culture, protein chemistry, and immunology.

Publications Top Notes:

  1. Interaction of Jania rubens Polyphenolic Extract as an Antidiabetic Agent with α-Amylase, Lipase, and Trypsin 🧑‍🔬🍀 (2024)
  2. Influence of Cedar Essential Oil on Polyvinyl Alcohol/Cedar Oil/Kaolin Composite Hydrogels 🌲💧 (2023)
  3. Preparation and Physicochemical Characterization of Gelatin–Aldehyde Derivatives 🧪🧬 (2022)
  4. Fatty N-Hexadecanyl Chitosan Derivatives for Biomedical Applications 🧬💉 (2022)
  5. Development of Polyvinyl Alcohol/Kaolin Sponges for Wound Healing Promotion 💉🌱 (2021)
  6. Green Cation Exchange Membrane Doped with Ceramic Nanotubes for Fuel Cells 🔋🔬 (2021)
  7. Effects of Octenyl Succinic Anhydride on Rice Starch Emulsions 🍚💡 (2020)
  8. Antimicrobial Activity of Modified Aminated Chitosan with Aromatic Esters 🦠🍃 (2019)
  9. Cinnamyl O-amine Functionalized Chitosan for Drug Delivery 💊🌿 (2019)
  10. Development of Polyelectrolyte Membranes for Direct Methanol Fuel Cells 🔋🧪 (2019)
  11. Smart Alginate/Chitosan Microcapsules for Colon-Specific Drug Delivery 💊👨‍🔬 (2019)

Conclusion:

Dr. Abdelrazik’s outstanding academic and research contributions make him a highly deserving candidate for the Research for Best Researcher Award. His consistent achievements in high-impact publications, leadership in research projects, and innovative scientific discoveries have placed him at the forefront of his field, solidifying his reputation as an influential researcher.